[{"id":"398611ec-32d5-4767-9ab0-d167a02f0c96","acronym":"ICE","url":"https://clinicaltrials.gov/study/NCT05727813","created_at":"2023-02-14T18:02:36.078Z","updated_at":"2024-07-02T16:35:55.606Z","phase":"","brief_title":"To Detect Cryoimmunologic Response Induced by Early Breast Cancer Ultrasound-guided Cryoablation (ICE-study)","source_id_and_acronym":"NCT05727813 - ICE","lead_sponsor":"University of Roma La Sapienza","biomarkers":" IL6 • CXCL8 • IL2RA • CXCL9 • IL10 • HMGB1 • CCL11 • CCL2 • IL17A • CCL3 • IL13 • IL15 • IL1R1 • IL4 • IL5 • IL7","pipe":"","alterations":" ","tags":["IL6 • CXCL8 • IL2RA • CXCL9 • IL10 • HMGB1 • CCL11 • CCL2 • IL17A • CCL3 • IL13 • IL15 • IL1R1 • IL4 • IL5 • IL7"],"overall_status":"Completed","enrollment":" Enrollment 20","initiation":"Initiation: 09/01/2022","start_date":" 09/01/2022","primary_txt":" Primary completion: 01/16/2023","primary_completion_date":" 01/16/2023","study_txt":" Completion: 01/27/2023","study_completion_date":" 01/27/2023","last_update_posted":"2023-02-14"},{"id":"0dd3a28d-1be7-40ff-a066-40868ec0b07e","acronym":"KG 4/2015","url":"https://clinicaltrials.gov/study/NCT02854072","created_at":"2021-01-18T14:00:33.938Z","updated_at":"2024-07-02T16:37:27.514Z","phase":"Phase 3","brief_title":"A Phase III Study to Assess the Efficacy and Safety of GV1001-Gem/Cap vs Gem/Cap in Pancreatic Cancer Patients","source_id_and_acronym":"NCT02854072 - KG 4/2015","lead_sponsor":"Samsung Pharmaceutical Co., Ltd.","biomarkers":" CCL11 • CA 19-9","pipe":"","alterations":" ","tags":["CCL11 • CA 19-9"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e gemcitabine • capecitabine • LucaVax (tertomotide)"],"overall_status":"Unknown status","enrollment":" Enrollment 148","initiation":"Initiation: 11/01/2015","start_date":" 11/01/2015","primary_txt":" Primary completion: 05/01/2018","primary_completion_date":" 05/01/2018","study_txt":" Completion: 05/01/2018","study_completion_date":" 05/01/2018","last_update_posted":"2016-11-22"}]